Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven R Duncan, MD
University of Alabama at Birmingham
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
Steven R Duncan, MD - Loyola University
Chicago, Illinois, United States
Daniel Dilling, MD - Northwestern University
Chicago, Illinois, United States
Anthony Esposito, MD - University of Kansas
Kansas City, Kansas, United States
Mark Hamblin, MD - University of North Carolina
Chapel Hill, North Carolina, United States
Sean Callahan, MD - Temple University
Philadelphia, Pennsylvania, United States
Gerald R Criner, MD - Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Ross Summer, MD - University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Dan Kass, MD - University of Utah
Salt Lake City, Utah, United States
Mary Beth Scholand, MD
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2026
- Primary completion
- 30 Sept 2030
- Completion
- 31 Mar 2031
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 52
- Registry id
- NCT07674745
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.